Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
Prevention and handling of acute allergic and infusion reactions in oncologyM JoergerDeutsche Medizinische Wochenschrift (1946)|December 14, 2004
[Lethal polypharmacy in a patient with arterial hypertension]M Joerger, M DiethelmAnnals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2010
Small HER2-positive, node-negative breast cancer: who should receive systemic adjuvant treatment?M Joerger, B Thürlimann, J HuoberNeuroreport|November 5, 2008
Neural correlates of false memory disqualification by true recollection of feedbackTaylor M Joerger, Jennifer A MangelsJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 30, 2010
Bevacizumab-associated hyperlipoproteinemia type IIb in a patient with advanced invasive-ductal breast cancerM Joerger, W F Riesen, B ThürlimannCurrent Drug Targets|October 21, 2009
The role of pemetrexed in advanced non small-cell lung cancer: special focus on pharmacology and mechanism of actionM Joerger, A Omlin, T Cerny, et al.Onkologie|February 5, 2003
Postradiation high-grade myofibroblastic sarcoma of the prostate -- a rare entity of prostatic tumors -- responding to liposomal DoxorubicinM Joerger, C Oehlschlegel, T Cerny, et al.Gerontology|November 27, 2009
Antiangiogenic drugs in oncology: a focus on drug safety and the elderly - a mini-reviewS Boehm, C Rothermundt, D Hess, et al.Swiss Medical Weekly|March 20, 2002
Gemcitabine-related pulmonary toxicityM Joerger, A Gunz, R Speich, et al.Methods and Findings in Experimental and Clinical Pharmacology|November 13, 2004
Therapeutic drug monitoring of non-anticancer drugs in cancer patientsM Joerger, J H M Schellens, J H BeijnenPageof 5